You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cystic fibrosis

Mannitol dry powder for inhalation for treating cystic fibrosis

  • Technology appraisal guidance
  • Reference number: TA266
  • Published:  28 November 2012
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Research recommendations coming out of this guidance

  • NICE proposes that a clinical trial is needed to establish the relative effectiveness of mannitol compared with hypertonic saline.

Back to top